Tumor necrosis factor signaling H Wajant, K Pfizenmaier, P Scheurich Cell Death & Differentiation 10 (1), 45-65, 2003 | 3318 | 2003 |
The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor M Grell, E Douni, H Wajant, M Löhden, M Clauss, B Maxeiner, ... Cell 83 (5), 793-802, 1995 | 1760 | 1995 |
The Fas signaling pathway: more than a paradigm H Wajant Science 296 (5573), 1635-1636, 2002 | 1491 | 2002 |
NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling S Kreuz, D Siegmund, P Scheurich, H Wajant Molecular and cellular biology, 2001 | 797 | 2001 |
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor M Grell, H Wajant, G Zimmermann, P Scheurich Proceedings of the National Academy of Sciences 95 (2), 570-575, 1998 | 637 | 1998 |
The CD95 receptor: apoptosis revisited ME Peter, RC Budd, J Desbarats, SM Hedrick, AO Hueber, MK Newell, ... Cell 129 (3), 447-450, 2007 | 490 | 2007 |
The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators H Wajant, F Henkler, P Scheurich Cellular signalling 13 (6), 389-400, 2001 | 465 | 2001 |
Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF M Grell, G Zimmermann, E Gottfried, CM Chen, U Grünwald, DCS Huang, ... The EMBO journal, 1999 | 383 | 1999 |
TNFR1 and TNFR2 in the control of the life and death balance of macrophages H Wajant, D Siegmund Frontiers in cell and developmental biology 7, 91, 2019 | 365 | 2019 |
Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8 M Fotin-Mleczek, F Henkler, D Samel, M Reichwein, A Hausser, I Parmryd, ... Journal of cell science 115 (13), 2757-2770, 2002 | 355 | 2002 |
TNFR1‐induced activation of the classical NF‐κB pathway H Wajant, P Scheurich The FEBS journal 278 (6), 862-876, 2011 | 353 | 2011 |
Anti–tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis JH Egberts, V Cloosters, A Noack, B Schniewind, L Thon, S Klose, ... Cancer research 68 (5), 1443-1450, 2008 | 347 | 2008 |
NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP S Kreuz, D Siegmund, JJ Rumpf, D Samel, M Leverkus, O Janssen, ... The Journal of cell biology 166 (3), 369-380, 2004 | 311 | 2004 |
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis IH Engels, A Stepczynska, C Stroh, K Lauber, C Berg, R Schwenzer, ... Oncogene 19 (40), 4563-4573, 2000 | 310 | 2000 |
Differential activation of TRAIL-R1 and-2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative H Wajant, D Moosmayer, T Wüest, T Bartke, E Gerlach, U Schönherr, ... Oncogene 20 (30), 4101-4106, 2001 | 286 | 2001 |
Non-apoptotic Fas signaling H Wajant, K Pfizenmaier, P Scheurich Cytokine & growth factor reviews 14 (1), 53-66, 2003 | 279 | 2003 |
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma A Trauzold, D Siegmund, B Schniewind, B Sipos, J Egberts, D Zorenkov, ... Oncogene 25 (56), 7434-7439, 2006 | 271 | 2006 |
Death receptors H Wajant Essays in biochemistry 39, 53-71, 2003 | 256 | 2003 |
Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. T Weiss, M Grell, B Hessabi, S Bourteele, G Mueller, P Scheurich, ... Journal of immunology (Baltimore, Md.: 1950) 158 (5), 2398-2404, 1997 | 241 | 1997 |
Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling H Wajant, P Scheurich The international journal of biochemistry & cell biology 33 (1), 19-32, 2001 | 230 | 2001 |